Spinal Implants: New Device Fights Serious Infection Risk | PLOS One Study

Nearly one in ten patients undergoing spinal fusion surgery will develop a serious bacterial infection, even with standard preventative antibiotics. What we have is a particularly devastating complication, as these infections can be difficult to treat and may require further surgery. Now, researchers at Thomas Jefferson University are exploring a novel approach: an implantable “reservoir” of antibiotics delivered directly to the surgical site using ultrasound. The findings, recently published in PLOS One, offer a potential strategy to overcome the limitations of traditional antibiotic administration and reduce the risk of post-surgical infections.

The Challenge of Post-Surgical Infection

Surgical site infections (SSIs) represent a significant burden on healthcare systems globally. Whereas prophylactic antibiotics – those given before surgery – are routinely used, their effectiveness is limited. Bacteria can form biofilms on implanted devices, rendering them less susceptible to antibiotics. Systemic antibiotics can have side effects and contribute to the growing problem of antibiotic resistance. Spinal surgeries, in particular, carry a heightened risk due to the complexity of the procedure and the presence of foreign materials like screws and rods.

How the Antibiotic Reservoir Works

The Jefferson University team, led by Selin Isguven Billmyer and Priscilla Machado, developed a system using small pockets made of polylactic acid (PLA), a biodegradable polymer. These pockets are filled with antibiotics and implanted near the surgical site. The key innovation lies in the method of antibiotic release: focused ultrasound. When applied externally, the ultrasound waves cause the PLA pockets to rupture, delivering a concentrated dose of antibiotic directly to the area where infection is most likely to occur.

The study involved both in vitro (laboratory) and in vivo (animal) experiments. Researchers demonstrated that ultrasound could reliably rupture the PLA pockets, releasing the antibiotic. In a rabbit model of spinal fusion, the ultrasound-mediated delivery of antibiotics significantly reduced bacterial load compared to traditional antibiotic administration. The researchers used NIH R01 AR069119 funding and The Mullin Fund for Spinal Research at Thomas Jefferson University to support this work.

Beyond Spinal Fusion: Potential Applications

While the initial research focused on spinal surgery, the principle of localized, ultrasound-triggered antibiotic delivery could be applied to a wide range of orthopedic and other surgical procedures. Any surgery involving the implantation of hardware – hip replacements, knee replacements, fracture fixation – could potentially benefit from this approach. The ability to deliver high concentrations of antibiotics directly to the surgical site minimizes systemic exposure and may improve treatment outcomes.

Understanding the Limitations and Next Steps

It’s important to note that this research is still in its early stages. The study was conducted on a relatively small number of rabbits and further research is needed to confirm the findings in larger animal models and, in human clinical trials. The researchers acknowledge that the long-term effects of PLA degradation and the optimal antibiotic dosage for ultrasound-mediated delivery require further investigation. The study does not address the potential for antibiotic resistance developing as a result of this localized, high-dose approach, which will need to be carefully monitored.

The team is currently working on optimizing the PLA pocket design and ultrasound parameters to maximize antibiotic release and minimize potential side effects. They are also exploring different antibiotics that could be used in the reservoir. The next phase of research will likely involve larger animal studies to assess the safety and efficacy of the system before moving towards human clinical trials.

The Broader Context of Surgical Site Infection Prevention

Preventing surgical site infections requires a multi-faceted approach. The Centers for Disease Control and Prevention (CDC) outlines several key strategies, including proper hand hygiene, sterile surgical technique, appropriate antibiotic prophylaxis, and effective wound care. The CDC’s guidelines are regularly updated based on the latest evidence.

The development of new technologies, like the antibiotic reservoir described in the PLOS One study, represents an important step forward in the fight against SSIs. However, it’s crucial to remember that these technologies are not a silver bullet. Continued adherence to established infection control practices remains paramount.

What Comes Next: Clinical Trials and Refinement

The path from laboratory research to clinical practice is a long one. Before this antibiotic reservoir system can be used in patients, it must undergo rigorous testing in clinical trials. These trials will assess the safety, efficacy, and optimal dosage of the system in humans. Researchers will also need to carefully monitor for any potential side effects or complications. The success of these trials will determine whether this innovative approach can ultimately improve outcomes for patients undergoing surgery. Further research will also focus on tailoring the antibiotic selection within the reservoir to address the specific bacterial threats most common in different surgical settings.